Horm Metab Res 2023; 55(03): 176-183
DOI: 10.1055/a-2010-2345
Original Article: Endocrine Care

Glycemic Variability and Prognosis of Patients with Intracerebral Hemorrhage: A Meta-Analysis

Xu Jiao   *
1   Emergency Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
2   Clinical Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu, China
,
Huifang Wang   *
1   Emergency Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
2   Clinical Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu, China
,
Mingfei Li
1   Emergency Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
2   Clinical Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu, China
,
Yun Lu
1   Emergency Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
2   Clinical Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu, China
› Author Affiliations Funding Information Science & Technology Department of Guangdong Province — 2020B1111100009 Science & Technology Department of Sichuan Province — 2019YFS0040
› Further Information
Also available at
   Permissions and Reprints

Abstract

Glycemic disorder may affect the outcomes of patients with intracerebral hemorrhage (ICH). However, the association between glycemic variability (GV) and prognosis in these patients remains to be determined. We performed a meta-analysis to compressive the influence of GV on functional outcome and mortality in patients with ICH. Observational studies comparing the risks of poor functional outcome (defined as modified Rankin Scale>2) and all-cause mortality between ICH patients with higher versus lower acute GV were retrieved by systematic search of Medline, Web of Science, Embase, CNKI, and Wanfang databases. A random-effect model was used to pool the data after incorporating the between-study heterogeneity. Sensitivity analyses were performed to evaluate the stability of the findings. Eight cohort studies involving 3400 patients with ICH were included in the meta-analysis. The follow-up duration was within 3 months after admission. All of the included studies used standard deviation of blood glucose (SDBG) as the indicator of acute GV. Pooled results showed that ICH patients with higher SDBG were associated with a higher risk of poor functional outcome as compared to those with lower SDBG [risk ratio (RR): 1.84, 95% confidence interval (CI): 1.41 to 2.42, p<0.001, I2=0%]. In addition, patients with higher category of SDBG were also associated with a higher mortality risk (RR: 2.39, 95% CI: 1.79 to 3.19, p<0.001, I2=0%). In conclusion, high acute GV may be a predictor of poor functional outcome and mortality of patients with ICH.

Key words

intracerebral hemorrhage - glycemic variability - mortality - functional outcome - meta-analysis

* These authors contributed equally to this work.




Publication History

Received: 31 October 2022

Accepted after revision: 02 January 2023

Article published online:
27 February 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Cordonnier C, Demchuk A, Ziai W. et al. Intracerebral haemorrhage: current approaches to acute management. Lancet 2018; 392: 1257-1268
    CrossrefPubMedGoogle Scholar
  • 2 Greenberg SM, Ziai WC, Cordonnier C. et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American heart association/American stroke association. Stroke 2022; 53: e282-e361
    CrossrefPubMedGoogle Scholar
  • 3 van Asch CJ, Luitse MJ, Rinkel GJ. et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 167-176
    CrossrefPubMedGoogle Scholar
  • 4 Poon MT, Fonville AF, Al-Shahi Salman R.. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2014; 85: 660-667
    CrossrefPubMedGoogle Scholar
  • 5 Pinho J, Costa AS, Araujo JM. et al. Intracerebral hemorrhage outcome: A comprehensive update. J Neurol Sci 2019; 398: 54-66
    CrossrefPubMedGoogle Scholar
  • 6 Dorn AY, Sun PY, Sanossian N. et al. Admission glycemic gap in the assessment of patients with intracerebral hemorrhage. Clin Neurol Neurosurg 2021; 208: 106871
    CrossrefPubMedGoogle Scholar
  • 7 Tan X, He J, Li L. et al. Early hyperglycaemia and the early-term death in patients with spontaneous intracerebral haemorrhage: a meta-analysis. Intern Med J 2014; 44: 254-260
    CrossrefPubMedGoogle Scholar
  • 8 Zheng J, Yu Z, Ma L. et al. Association between blood glucose and functional outcome in intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg 2018; 114: e756-e765
    CrossrefPubMedGoogle Scholar
  • 9 Naidech AM, Levasseur K, Liebling S. et al. Moderate hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care 2010; 12: 181-187
    CrossrefPubMedGoogle Scholar
  • 10 Sadan O, Feng C, Vidakovic B. et al. Glucose variability as measured by inter-measurement percentage change is predictive of in-patient mortality in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2020; 33: 458-467
    CrossrefPubMedGoogle Scholar
  • 11 Ceriello A, Monnier L, Owens D.. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol 2019; 7: 221-230
    CrossrefPubMedGoogle Scholar
  • 12 Rodbard D.. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther 2018; 20: S25-S215
    CrossrefPubMedGoogle Scholar
  • 13 Lin J, Cai C, Xie Y.. Acute glycemic variability and functional outcome in patients with acute ischemic stroke: a meta-analysis. Horm Metab Res 2022; 54: 371-379
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lin J, Cai C, Xie Y. et al. Acute glycemic variability and mortality of patients with acute stroke: a meta-analysis. Diabetol Metab Syndr 2022; 14: 69
    CrossrefPubMedGoogle Scholar
  • 15 Pu Z, Lai L, Yang X. et al. Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis. Endocrine 2020; 67: 526-534
    CrossrefPubMedGoogle Scholar
  • 16 Li X, Zhang D, Chen Y. et al. Acute glycemic variability and risk of mortality in patients with sepsis: a meta-analysis. Diabetol Metab Syndr 2022; 14: 59
    CrossrefPubMedGoogle Scholar
  • 17 Kurtz P, Claassen J, Helbok R. et al. Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study. Crit Care 2014; 18: R89
    CrossrefPubMedGoogle Scholar
  • 18 Guo MF, Sun BL.. Relationship between blood glucose and its variability with prognosis in patients with severe intracerebral hemorrhage. Zhejiang Clin Med 2015; 17: 1953-1954
    PubMedGoogle Scholar
  • 19 Okazaki T, Hifumi T, Kawakita K. et al. Blood glucose variability: a strong independent predictor of neurological outcomes in aneurysmal subarachnoid hemorrhage. J Intensive Care Med 2018; 33: 189-195
    CrossrefPubMedGoogle Scholar
  • 20 Wada S, Yoshimura S, Inoue M. et al. Outcome prediction in acute stroke patients by continuous glucose monitoring. J Am Heart Assoc 2018; 7
    PubMedGoogle Scholar
  • 21 Wu YC, Ding Z, Wu J. et al. Increased glycemic variability associated with a poor 30-day functional outcome in acute intracerebral hemorrhage. J Neurosurg 2018; 129: 861-869
    CrossrefPubMedGoogle Scholar
  • 22 Chen SP, Lei KL, Sun HL.. The correlation analysis between blood glucose variability and prognosis in patients withs evere acute cerebral hemorrhage. Chin J Pract Nerv Dis 2020; 23: 1973-1978
    PubMedGoogle Scholar
  • 23 Gao PT, Fu ZQ.. The correlation between blood glucose variability and neurological function recovery in patients with severe cerebral hemorrhage. Stroke Nerv Dis 2020; 27: 604-613
    PubMedGoogle Scholar
  • 24 Santana D, Mosteiro A, Pedrosa L. et al. Clinical relevance of glucose metrics during the early brain injury period after aneurysmal subarachnoid hemorrhage: an opportunity for continuous glucose monitoring. Front Neurol 2022; 13: 977307
    CrossrefPubMedGoogle Scholar
  • 25 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
    Google Scholar
  • 26 Page MJ, Moher D, Bossuyt PM. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021; 372: n160
    CrossrefPubMedGoogle Scholar
  • 27 Higgins J, Thomas J, Chandler J. et al. Cochrane handbook for systematic reviews of interventions version 6.2. The Cochrane Collaboration. 2021 www.training.cochrane.org/handbook
    PubMedGoogle Scholar
  • 28 Breyton AE, Lambert-Porcheron S, Laville M. et al. CGMS and glycemic variability, relevance in clinical research to evaluate interventions in T2D, a literature review. Front Endocrinol (Lausanne) 2021; 12: 666008
    CrossrefPubMedGoogle Scholar
  • 29 Acosta JN, Leasure AC, Kuohn LR. et al. Admission hemoglobin levels are associated with functional outcome in spontaneous intracerebral hemorrhage. Crit Care Med 2021; 49: 828-837
    CrossrefPubMedGoogle Scholar
  • 30 Wells GA, Shea B, O'Connell D. et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
    PubMed
  • 31 Ziff OJ, Lane DA, Samra M. et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ 2015; 351: h4451
    CrossrefPubMedGoogle Scholar
  • 32 Higgins JP, Thompson SG.. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
    CrossrefPubMedGoogle Scholar
  • 33 Patsopoulos NA, Evangelou E, Ioannidis JP.. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008; 37: 1148-1157
    CrossrefPubMedGoogle Scholar
  • 34 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
    CrossrefPubMedGoogle Scholar
  • 35 Valente T, Arbex AK.. Glycemic variability, oxidative stress, and impact on complications related to type 2 diabetes mellitus. Curr Diabetes Rev 2021; 17: e071620183816
    CrossrefPubMedGoogle Scholar
  • 36 Papachristoforou E, Lambadiari V, Maratou E. et al. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res 2020; 7489795
    PubMedGoogle Scholar
  • 37 Zheng Y, Li R, Fan X.. Targeting oxidative stress in intracerebral hemorrhage: prospects of the natural products approach. Antioxidants (Basel) 2022; 11
    PubMedGoogle Scholar
  • 38 Zhang Y, Khan S, Liu Y. et al. Oxidative stress following intracerebral hemorrhage: from molecular mechanisms to therapeutic targets. Front Immunol 2022; 13: 847246
    CrossrefPubMedGoogle Scholar
  • 39 Yao Z, Bai Q, Wang G.. Mechanisms of oxidative stress and therapeutic targets following intracerebral hemorrhage. Oxid Med Cell Longev 2021; 8815441
    PubMedGoogle Scholar